Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy

Published:2015-05-15 Issue:5 Volume:20 Page:8823-8855
ISSN:1420-3049
Container-title:Molecules
language:en
Short-container-title:Molecules

Author:

van Westering Tirsa,Betts Corinne,Wood Matthew

Funder

Muscular Dystrophy UK

British Heart Foundation

Publisher

MDPI AG

Subject

Chemistry (miscellaneous),Analytical Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Molecular Medicine,Drug Discovery,Pharmaceutical Science

Link

http://www.mdpi.com/1420-3049/20/5/8823/pdf

Reference203 articles.

1. The Heart in Human Dystrophinopathies

2. Clinical Investigation of Duchenne Muscular Dystrophy

3. Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics

4. Splicing therapy for neuromuscular disease

5. Molecular mechanisms of muscular dystrophies: old and new players

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High mobility group box 1 (HMGB1) is a potential disease biomarker in cell and mouse models of Duchenne muscular dystrophy;Biology Open;2024-09-05

2. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response;Cells;2024-07-09

3. In vivo evaluation of the redox alteration in Duchenne muscular dystrophy in mdx mice using dynamic nuclear polarization magnetic resonance imaging;2024-06-06

4. Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy;Cells;2024-01-15

5. Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1;Molecular Therapy - Nucleic Acids;2023-12